Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes

References

• Morrison D C, Ryan J L. Endotoxins and disease mechanisms. Ann Rev Med 1987; 38: 417–32
   PubMed Web of Science ®Google Scholar
• van Deventer S JH, Büller H R, ten Cate J W, Aar-Den L A, Hack E, Sturk A. Experimental endotoxe-mia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520–6
   PubMed Web of Science ®Google Scholar
• Nathan C F. Secretory products of macrophages. J Clin Invest 1978; 79: 319–26
   Google Scholar
• Sherry B, Cerami A. Cachectin/Tumor necrosis factor exerts endocrine, paracine and autocrine control of inflammatory responses. J Cell Biol 1988; 107: 1269–77
   PubMed Web of Science ®Google Scholar
• Lyberg T. Clinical significance of increased thromboplastin activity on the monocyte surface–A brief review. Haemostasis 1984; 14: 430–9
   PubMedGoogle Scholar
• Suffredini A F, Harpel P C, Parillo J E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 18: 1165–72
   Google Scholar
• Ulevitch R J, Johnston A R, Weinstein D B. New function for high density lipoproteins. Their participation in intravascular reactions of bacterial lipo-polysaccharides. J Clin Invest 1979; 64: 1516–24
   PubMed Web of Science ®Google Scholar
• Flegel W A, Wolpl A, Mannel D A, Northoff H. Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins. Infect Immun 1989; 57: 2237–45
   PubMed Web of Science ®Google Scholar
• Freudenberg M A, Bog-Hansen T C, Back U, Galanos C. Interaction of lipopolysaccharides with plasma high-density lipoprotein in rats. Infect Immun 1980; 28: 373–80
   PubMedGoogle Scholar
• Harris H W, Grunfeld C, Feingold K R, Rapp J H. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 1990; 86: 696–702
   PubMed Web of Science ®Google Scholar
• Baumberger C, Ulevitch R J, Dayer J-M. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 1991; 59: 378–83
   PubMed Web of Science ®Google Scholar
• Van Lenten B J, Fogelman A M, Haberland M E, Edwards P A. The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci 1986; 83: 2704–8
   PubMed Web of Science ®Google Scholar
• Mathison J C, Ulevitch R J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979; 123: 2133–43
   PubMed Web of Science ®Google Scholar
• Ulevitch R J, Johnston A R. The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest 1978; 62: 1313–24
   PubMed Web of Science ®Google Scholar
• Eichbaum E B, Harris H W, Kane J P, Rapp J H. Chylomicrons can inhibit endotoxin activity in vitro. J Surg Res 1991; 51: 413–6
   PubMed Web of Science ®Google Scholar
• Weinstock C, Ullrich H, Hohe R, et al. Low density lipoproteins inhibit endotoxin activation of monocytes. Arteriosclerosis Thrombosis 1992; 12: 341–7
   PubMedGoogle Scholar
• Abdelnoor A M, Harvie N R, Johnson A G. Neutralization of bacteria- and endotoxin-induced hypotension by lipoprotein-free human serum. Infect Immun 1982; 38: 157–61
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P, Bryn K, Kierulf P, et al. Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultra-centrifugation, and electron microscopy. J Clin Invest 1992; 89: 816–23
   PubMed Web of Science ®Google Scholar
• Labischinski H, Barnickel G, Bradaczek H, Naumann D, Rietschel E T, Giesbrecht P. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol 1985; 162: 9–20
   PubMed Web of Science ®Google Scholar
• Aune S, Aasen A O, Kierulf P, Stremme J H. Quantitative determination of endotoxin in plasma by means of a new chromogenic peptide substrate. A methodological study. Acta Chir Scand 1982; 509: 55–7
   Google Scholar
• Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21(suppl. 97)77–89
   PubMed Web of Science ®Google Scholar
• Havel R J, Eder H A, Bragdon J H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
   PubMed Web of Science ®Google Scholar
• Hvatum M, Prydz H. Studies on tissue thromboplastin. Solubilization with sodium deoxycholate. Biochem Biophys Acta 1966; 130: 92–101
   Google Scholar
• Hjort P F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand J Clin Invest 1978; 9(suppl. 27)
   Google Scholar
• Markwell M AK, Haas S M, Bieber L L, Tolbert N E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978; 87: 206–10
   PubMed Web of Science ®Google Scholar
• Weinberg J B, Hobbs M M, Pizo S V. Microassay for the photometric quantitation of cell-associated plasminogen activator using a chromogenic tripep-tide substrate. J Immunol Methods 1984; 75: 289–94
   PubMedGoogle Scholar
• Rasmussen L-T, Seljelid R. The modulatory effect of lipoproteins on the release of interleukin 1 by human peritoneal macrophages stimulated with β-1,3-D-Polyglucose derivatives. Scand J Immunol 1989; 29: 477–84
   Google Scholar
• Emanicpator K, Csako G, Elin R J. In vitro inactivation of bacterial endotoxin by human lipoproteins and apolipoproteins. Infect Immun 1991; 60: 596–601
   Google Scholar
• Henriksen T, Evensen S A, Carlander B. Injury to human endothelial cells in culture induced by low density lipoproteins. Scand J Clin Lab Invest 1979; 39: 361–8
   PubMed Web of Science ®Google Scholar
• Morel D W, DiCorleto P E, Chisolm G M. Modulation of endotoxin-induced endothelial cell toxicity by low density lipoprotein. Lab Invest 1986; 55: 419–26
   PubMed Web of Science ®Google Scholar
• Cavaillon J M, Fitting C, Haeffner-Cavaillon N, Kirsch S J, Warren H S. Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide. Infect Immun 1990; 58: 2375–82
   PubMedGoogle Scholar
• Homma R, Kuratsuka K, Akama K. Application of the LAL test and the chromogenic substrate test to the detection of endotoxin in human blood products. Endotoxins and their Detection with the Limulus Amebocyte Lysate Test, S W Watson, J Levein, T J Novitsky. Alan R. Liss, Inc., New York 1982; 301–17
   Google Scholar
• Weary M, Pearson F C, Bohon J, Donohue G. The activity of various endotoxins in the USP rabbit test and in three different LAL tests. Endotoxins and their Detection with the Limulus Amebocyte Lysate Test, S W Watson, J Levin, T J Novitsky. Alan R. Liss, Inc., New York 1982; 365–79
   Google Scholar
• Roth R I, Yamasaki R, Mandrell R E, McLeod Grifflss J. Ability of gonococcal and meningococcal Lipooligosaccharides to clot Limulus Amebocyte Lysate. Infect Immun 1992; 60: 762–7
   PubMedGoogle Scholar
• van Lenten B J, Fogelmann A M, Jackson R L, Shapiro S, Haberland M E, Edwards P A. Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte/macrophages. J Biol Chem 1985; 60: 8783–8
   Google Scholar
• Sakai T, Kisiel W. Formation of tissue factor activity following incubation of recombinant human tissue factor apoprotein with plasma lipoproteins. Thromb Res 1990; 60: 213–22
   Google Scholar
• Schwartz B S, Levy G A, Curtiss L K, Fair D S, Edgington T S. Plasma lipoprotein induction and suppression of the generation of cellular procoagu-lant activity in vitro. J Clin Invest 1981; 67: 1650–8
   PubMed Web of Science ®Google Scholar
• Levy G A, Schwartz B S, Curtiss L K, Edgington T S. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro. Requirements for cellular cooperation. J Clin Invest 1981; 67: 1614–22
   PubMed Web of Science ®Google Scholar
• Schuff-Werner P, Claus G, Armstrong V W, Kostering H, Seidel D. Enhanced procoagulant activity (PCA) of human monocytes/macrophages after in vitro stimulation with chemically modified LDL. Atherosclerosis 1989; 78: 109–12
   Google Scholar
• Schwartz B S, Monroe M C, Bradshaw J D. Endo-toxin-induced production of plasminogen activator inhibitor by human monocytes is autonomous and can be inhibited by Lipid X. Blood 1989; 73: 2188–95
   PubMedGoogle Scholar
• Lyberg T, Kierulf P, Øvstebø R, Gangnæs Hammer A K. Coordinate expression of procoagulant, fibrinolytic and antifibrinolytic activities in human monocytes in vitro. Thromb Haemostas 1989; 62: 68
   Google Scholar
• Gold M R, Miller C L, Mishell R I. Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. Infect Immun 1985; 49: 731–41
   Google Scholar
• Drapier J C, Lemaire G, Petit J F. Regulation of plasminogen activator secretion in mouse peritoneal macrophages II. Inhibition by immuno-modulators of bacterial origin. Int J Immunophar-macol 1982; 4: 21–34
   Google Scholar
• Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067–73
   PubMedGoogle Scholar
• Etingin O R, Hajjar D P, Hajjar K A, Harpel P C, Nachman R L. Lipoprotein(a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. J Biol Chem 1991; 226: 2459–65
   Google Scholar
• Eaton D L, Fless G M, Kohr W J, et al. Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci 1987; 84: 3224–8
   PubMedGoogle Scholar
• Gonzalez-Gronow M, Edelberg J M, Pizzo S V. Further characterization of the cellular plasminogen binding site: Evidence that plasminogen 2 and lipoprotein(a) compete for the same site. Biochemistry 1989; 28: 2374–7
   Google Scholar
• Miles L A, Fless G M, Levin E G, Scanu A M, Plow F F. A potential basis for the thrombotic risks associated with lipoprotein(a). nature 1989; 339: 301–3
   PubMed Web of Science ®Google Scholar
• Drake T A, Hannai K, Fei H, Lavi S, Berliner J A. Minimally oxidized LDL induces tissue factor expression in cultured human endothelial cells. Am J Pathol 1991; 138: 601–7
   PubMed Web of Science ®Google Scholar